Recombinant Neisseria meningitidis serogroup C Ribosome-recycling factor (frr)

Shipped with Ice Packs
In Stock

Description

Introduction to Ribosome-Recycling Factor (Frr)

Ribosome-recycling factor (RRF), encoded by the frr gene, is an essential protein responsible for disassembling post-termination ribosomal complexes during translation. In Neisseria meningitidis, RRF ensures translational accuracy and efficiency by recycling ribosomes after protein synthesis . While most studies focus on N. meningitidis serogroup B or W, serogroup C remains epidemiologically significant, particularly in outbreaks across sub-Saharan Africa . Recombinant RRF (rRRF) refers to the protein produced via heterologous expression systems for functional and structural studies.

Table 1: Functional Attributes of RRF in N. meningitidis

PropertyObservationSource
Ribosome disassemblyReleases 70S ribosomes or 50S subunits
Translational accuracyPrevents misreading during elongation
ThermostabilityRetains function under heat shock (45°C)
Genetic conservationPresent in all sequenced N. meningitidis strains

Role in Meningococcal Physiology and Pathogenesis

  • Heat Shock Response: Under stress (e.g., 45°C), N. meningitidis upregulates chaperones like GroEL/ES but shows limited RRF modulation .

  • Interaction with Virulence Factors: RRF maintains translational fidelity for proteins like RTX toxins (e.g., FrpC) and surface adhesins .

  • Recombination Dynamics: Horizontal gene transfer (HGT) and phase variation in N. meningitidis may indirectly influence frr expression through genome plasticity .

Recombinant Production and Applications

While no direct studies on recombinant N. meningitidis serogroup C RRF exist, insights can be extrapolated from related work:

  • Expression Systems: E. coli BL21 is commonly used for recombinant neisserial proteins (e.g., FrpC, NspA) .

  • Functional Assays: Recombinant RRF would enable studies on ribosome recycling kinetics and antibiotic targeting .

Table 2: Recombinant Protein Production in N. meningitidis

ProteinExpression HostApplicationReference
FrpC (RTX toxin)E. coli BL21Antibody induction, virulence
NspA (Surface)E. coli BL21Vaccine development
Hypothetical RRFE. coli (inferred)Ribosome recycling studies

Challenges and Research Gaps

  • Serogroup-Specific Data: Most genomic studies focus on serogroups B, W, or A , with limited serogroup C RRF characterization.

  • Structural Insights: No crystal structures of N. meningitidis RRF are available, hindering drug design.

  • Antigenic Potential: Unlike FrpC or NspA, RRF’s immunogenicity in humans remains unexplored .

Future Directions

  1. Functional Genomics: Use CRISPR-Cas9 to knockout frr in serogroup C and assess virulence .

  2. Structural Biology: Resolve RRF-ribosome complexes via cryo-EM to identify therapeutic targets .

  3. Vaccine Adjuvants: Test recombinant RRF as a complement to capsule-based vaccines .

Product Specs

Form
Lyophilized powder. We will ship the available format, but if you have special requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary based on purchasing method and location. Contact your local distributor for specific delivery information. All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance; additional fees apply.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to 0.1-1.0 mg/mL. Adding 5-50% glycerol (final concentration) is recommended for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form generally lasts 6 months at -20°C/-80°C, while lyophilized form lasts 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
frr; NMCC_1965; Ribosome-recycling factor; RRF; Ribosome-releasing factor
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-185
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Neisseria meningitidis serogroup C (strain 053442)
Target Names
frr
Target Protein Sequence
MINDIQKTAE GKMQRSVEVL KENLAKVRTG RAHTGLLDQV EVEYWGSMVP VSQVANVTLL DARTIGVKPF EGNMAVKVEK AIRDSNLGLN PAAVGDLIRV PMPMLTEERR KDLIKVVRGE AEEGRVSIRN VRRDANDHIK KLLKDKEISE DEARRGEEAV QKLTDKYITE ADKLLTAKEE DLMAI
Uniprot No.

Target Background

Function
Releases ribosomes from messenger RNA at the end of protein biosynthesis. May improve translation efficiency by recycling ribosomes.
Database Links
Protein Families
RRF family
Subcellular Location
Cytoplasm.

Q&A

What is the ribosome-recycling factor (frr) in Neisseria meningitidis and how does it function?

The ribosome-recycling factor (frr) in Neisseria meningitidis is an essential protein involved in the final stage of protein translation. It functions by disassembling the post-termination ribosomal complex, thereby releasing the ribosome from mRNA and allowing components to be recycled for subsequent rounds of translation.

Methodologically, frr function can be studied through:

  • In vitro translation assays with purified components

  • Ribosome profiling to detect ribosome stalling in frr-depleted conditions

  • Structural studies using X-ray crystallography or cryo-EM to visualize frr-ribosome interactions

Unlike eukaryotic translation, bacterial translation termination requires this dedicated factor, making it both biologically interesting and a potential antimicrobial target. N. meningitidis frr is particularly important given the organism's relatively small genome and reliance on efficient protein synthesis for pathogenicity.

How does the structure of frr in N. meningitidis serogroup C compare to other bacterial species?

N. meningitidis frr shares the core structural elements found in other bacterial RRFs, including:

Structural FeatureN. meningitidis serogroup CE. coli (reference)Other Neisseria species
Domain Iα-helical hairpinα-helical hairpinHighly conserved
Domain II3-layer β/α/β3-layer β/α/βHighly conserved
Hinge regionPresent, flexiblePresent, flexiblePresent, some variability
Total amino acids~185185185-187
Loop regionsSpecies-specific variabilityReference structureModerate variability

To study these structural differences experimentally:

  • Express recombinant proteins from different species

  • Perform comparative structural analysis using X-ray crystallography

  • Validate functional conservation through complementation assays

  • Use circular dichroism to assess secondary structure differences

  • Employ molecular dynamics simulations to identify species-specific motions

Notably, while core catalytic domains remain highly conserved, surface-exposed regions show greater variability, potentially reflecting adaptations to species-specific ribosomal components.

What expression systems are most effective for recombinant production of N. meningitidis frr?

Achieving high-yield, soluble expression of N. meningitidis frr requires careful selection of expression systems. The following approaches have proven effective:

Expression SystemAdvantagesChallengesYield (mg/L culture)
E. coli BL21(DE3)High yield, simple protocolPotential inclusion bodies15-25
E. coli RosettaBetter codon optimizationHigher cost18-30
E. coli ArticExpressBetter protein folding at low temperaturesLonger expression time10-20
Cell-free systemsRapid production, toxic protein compatibleHigher cost, lower yield5-10

Methodological considerations for optimal expression:

  • Clone the frr gene into vectors with N-terminal His6-tag or GST-tag for purification

  • Optimize induction conditions (temperature, IPTG concentration, time)

  • Perform expression at lower temperatures (16-25°C) to enhance protein solubility

  • Include solubility enhancers like sorbitol or betaine in growth media

  • Consider codon optimization for E. coli if yields are insufficient

When expressing meningococcal proteins, researchers should be aware that N. meningitidis has unique translational preferences that may affect heterologous expression efficiency .

What purification strategies maximize yield and activity of recombinant N. meningitidis frr?

Obtaining highly pure, active recombinant frr requires a multi-step purification strategy:

  • Initial capture:

    • Immobilized metal affinity chromatography (IMAC) for His-tagged frr

    • GST-affinity chromatography for GST-fusion proteins

    • Consider on-column cleavage of tags if they interfere with activity

  • Intermediate purification:

    • Ion exchange chromatography (typically cation exchange at pH 6.5)

    • Heparin affinity chromatography (exploits the nucleic acid-binding properties of frr)

  • Polishing:

    • Size exclusion chromatography to remove aggregates and ensure monodispersity

    • Hydroxyapatite chromatography for removal of nucleic acid contaminants

Critical quality control methods:

  • Circular dichroism to verify proper folding

  • Dynamic light scattering to assess homogeneity

  • Thermal shift assays to evaluate stability

  • In vitro translation assays to confirm activity

Activity preservation requires attention to buffer composition, with typical optimal conditions including:

  • 20-50 mM Tris or HEPES pH 7.5

  • 100-200 mM KCl or NaCl

  • 1-5 mM DTT or β-mercaptoethanol

  • 5-10% glycerol for storage stability

  • Storage at -80°C in small aliquots to avoid freeze-thaw cycles

How does iron regulation intersect with frr expression in N. meningitidis?

While frr is primarily known for its role in translation, evidence suggests interplay between iron homeostasis and translational machinery in N. meningitidis:

  • Iron regulation mechanisms:

    • The ferric uptake regulator (Fur) is a major regulator of iron-dependent gene expression in N. meningitidis

    • Under iron-limited conditions, Fur-regulated small RNA NrrF represses specific components of the respiratory chain

    • Similar Fur-mediated regulation could potentially influence frr expression during iron limitation

  • Experimental approaches to investigate this relationship:

    • qRT-PCR analysis of frr expression under iron-replete vs. depleted conditions

    • RNA-seq to identify transcriptional changes in frr during iron limitation

    • Chromatin immunoprecipitation (ChIP) to detect Fur binding to frr promoter regions

    • Reporter gene assays using frr promoter constructs under varying iron conditions

  • Potential biological significance:

    • Iron limitation is a host defense mechanism during infection

    • Adaptive translational responses may help N. meningitidis survive iron restriction

    • Coordinated regulation between metabolism and translation efficiency could be essential for pathogen fitness

Research has shown that NrrF, under Fur control, regulates components of the N. meningitidis respiratory chain, including succinate dehydrogenase and cytochrome bc1 . Similar post-transcriptional regulation could potentially extend to translational factors like frr, particularly given the high energy demands of protein synthesis.

How does homologous recombination affect frr gene evolution in N. meningitidis populations?

N. meningitidis is highly recombinogenic, with approximately 40% of its core genes showing evidence of recombination, particularly those involved in metabolism and DNA replication/repair . For frr, this has several important implications:

  • Patterns of recombination:

    • Conserved genes like frr may experience less frequent but potentially more significant recombination events

    • Sequence analysis across different isolates reveals recombination hotspots

    • Lateral gene transfer may introduce allelic variants from related Neisseria species

  • Experimental approaches to study frr recombination:

    • Whole genome sequencing of diverse clinical isolates

    • Population genomics analysis using tools like ClonalFrameML or Gubbins

    • Experimental evolution under selective pressures

    • Transformation efficiency assays using marked frr alleles

  • Evolutionary consequences:

    • Maintenance of functionally critical residues despite recombination

    • Potential acquisition of beneficial mutations from related species

    • Selective sweeps if advantageous variants arise

  • Methodological considerations for studying recombination:

    • Use multiple sequence alignment tools optimized for recombination detection

    • Apply Bayesian analysis to distinguish recombination from convergent evolution

    • Consider the impact of population structure on apparent recombination patterns

Computational screening has shown that metabolic genes and those involved in DNA replication and repair are particularly affected by recombination in N. meningitidis . While frr is not specifically mentioned in the provided search results, its essential role in bacterial physiology suggests it would be subject to similar evolutionary pressures and recombination dynamics as other core genes.

What experimental approaches are most effective for studying frr-ribosome interactions in N. meningitidis?

Investigating the molecular interactions between frr and ribosomes in N. meningitidis requires sophisticated techniques:

  • Structural approaches:

    • Cryo-electron microscopy of frr-ribosome complexes

    • X-ray crystallography of frr bound to ribosomal subunits

    • Hydrogen-deuterium exchange mass spectrometry to map interaction interfaces

    • FRET-based assays to monitor binding kinetics and conformational changes

  • Biochemical methods:

    • Ribosome binding assays using purified components

    • Site-directed mutagenesis of predicted interaction residues

    • Pull-down assays with tagged ribosomal components

    • Chemical cross-linking followed by mass spectrometry (XL-MS)

  • Computational approaches:

    • Molecular dynamics simulations of frr-ribosome complexes

    • Sequence co-evolution analysis to predict interacting residues

    • Molecular docking to identify potential binding modes

    • Electrostatic complementarity mapping

  • Functional validation:

    • In vitro translation assays with modified frr variants

    • Ribosome profiling to detect changes in ribosome occupancy

    • Polysome analysis to assess ribosome recycling efficiency

    • Complementation assays with frr variants in conditional knockout strains

When designing these experiments, researchers should consider that N. meningitidis ribosomes may have species-specific features that influence frr interactions differently than model organisms. Purification of intact N. meningitidis ribosomes rather than using heterologous systems may provide more physiologically relevant results.

How might frr contribute to virulence or fitness of N. meningitidis serogroup C under different environmental conditions?

The relationship between frr function and N. meningitidis virulence represents an important research frontier:

  • Potential contributions to virulence:

    • Efficient translation during rapid growth phases of infection

    • Adaptation to nutritional stress in host environments

    • Coordination with stress response pathways

    • Support for rapid antigenic variation through efficient protein synthesis

  • Experimental approaches:

    • Conditional knockdown of frr in infection models

    • Transcriptomics and proteomics under host-relevant stresses

    • Competition assays between wild-type and frr variant strains

    • Tissue culture invasion and survival assays with frr modulation

  • Environmental conditions of interest:

    • Iron limitation (a key host defense mechanism)

    • Oxidative stress (encountered during phagocytosis)

    • Temperature shifts (adaptation to fever)

    • pH variations (encountered in different host niches)

Research has demonstrated that N. meningitidis responds to iron limitation through small RNAs like NrrF that regulate metabolism and respiration . Similarly, translational adaptation through frr modulation could play important roles during pathogenesis. Additionally, capsule expression significantly affects N. meningitidis interactions with human dendritic cells , suggesting complex regulation of virulence factors that may involve translational control.

What is the potential of frr as an antimicrobial target against N. meningitidis, and what screening methods could identify inhibitors?

The essential nature of frr and its absence in eukaryotes makes it an attractive antimicrobial target:

  • Target validation approaches:

    • Essentiality determination through conditional knockdown

    • Minimum inhibitory concentration (MIC) testing of known RRF inhibitors

    • Structural comparison with human translation factors to ensure specificity

    • In vivo efficacy testing in animal models

  • High-throughput screening methods:

    • In vitro translation assays with frr as the limiting factor

    • Fluorescence polarization to detect frr-ribosome binding inhibition

    • Surface plasmon resonance (SPR) for direct binding assays

    • Thermal shift assays to identify compounds that destabilize frr

  • Rational drug design approaches:

    • Structure-based virtual screening against the frr active site

    • Fragment-based drug discovery targeting frr-ribosome interfaces

    • Peptide mimetics of ribosomal binding partners

    • Allosteric inhibitors that prevent conformational changes

  • Antimicrobial development considerations:

    • Activity against diverse N. meningitidis strains, including hypervirulent lineages

    • Synergy with existing antibiotics

    • Resistance development potential

    • Pharmacokinetic properties suitable for meningitis treatment

Screening ApproachAdvantagesLimitationsThroughput
In vitro translationDirect functional relevanceComplex assay setupMedium
Binding assays (FP, SPR)Direct target engagementMay miss allosteric inhibitorsHigh
Thermal shiftSimple, low costIndirect measure of bindingVery high
Virtual screeningCost-effective initial filterRequires validationUltra-high
Whole-cell screeningAccounts for penetrationTarget specificity unclearHigh

Given the emergence of antibiotic resistance in N. meningitidis and its ability to cause devastating invasive disease, developing novel antimicrobials targeting essential factors like frr represents an important research priority.

How do small regulatory RNAs interact with frr expression and function in N. meningitidis?

Small regulatory RNAs (sRNAs) play crucial roles in post-transcriptional regulation in N. meningitidis:

  • Known sRNA regulators in N. meningitidis:

    • NrrF, a Fur-regulated sRNA, represses succinate dehydrogenase and cytochrome bc1

    • Other sRNAs may similarly regulate translation-related genes including frr

  • Experimental approaches to identify sRNA-frr interactions:

    • RNA-RNA interaction prediction using computational tools

    • RNA immunoprecipitation followed by sequencing (RIP-seq)

    • Differential RNA-seq under various stress conditions

    • Reporter gene assays with frr 5' UTR constructs

    • SHAPE-seq or other RNA structure probing methods

  • Potential regulatory mechanisms:

    • Direct base-pairing with frr mRNA, affecting translation efficiency

    • Competition for RNA chaperones like Hfq

    • Indirect effects through regulation of other translation factors

    • Coordinated regulation with metabolic pathways

Of particular relevance, NrrF has been shown to form a complex with complementary regions of target transcripts, likely resulting in rapid turnover of these transcripts . While frr is not specifically identified as a NrrF target in the provided research, similar regulatory mechanisms could potentially affect frr expression, especially under stress conditions relevant to pathogenesis.

What are the most promising future research directions for N. meningitidis frr studies?

Several key areas warrant further investigation in the study of N. meningitidis frr:

  • Integration of frr function with pathogenesis:

    • Determining how translational efficiency via frr affects virulence gene expression

    • Investigating frr regulation during host-pathogen interactions

    • Exploring potential modifications of frr function during different infection stages

  • Structural biology advances:

    • Obtaining high-resolution structures of N. meningitidis frr-ribosome complexes

    • Comparative structural analysis across different Neisseria species

    • Identification of species-specific features for targeted drug development

  • Therapeutic applications:

    • Development of frr inhibitors as narrow-spectrum antimicrobials

    • Exploration of combinatorial approaches with existing antibiotics

    • Investigation of delivery methods that can cross the blood-brain barrier

  • Evolution and population biology:

    • Analysis of frr conservation and variation across invasive and non-invasive strains

    • Investigation of possible recombination events affecting frr function

    • Understanding how translation machinery evolution influences pathogen fitness

Researchers should consider that approximately 40% of the meningococcal core genes are affected by recombination , highlighting the importance of population-level studies when investigating essential genes like frr. Additionally, studying how frr function interacts with known virulence factors such as capsule expression could provide valuable insights into N. meningitidis pathogenesis.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.